You’re going to see lithium everywhere in psych question banks—not because it’s the “best” medication, but because it’s high-yield, nuanced, and full of testable toxicities and interactions. The trick isn’t just recognizing lithium as the correct answer; it’s knowing why the other choices are almost right—and exactly when they are right.
Tag: Psychiatry > Psychotic & Mood Disorders
The Vignette (Classic Q-bank Style)
A 28-year-old woman is brought to clinic by her partner because she “hasn’t slept in 5 days” and has been starting multiple business ventures. She is extremely talkative, distractible, and irritable. She reports “special messages” in billboards and believes she was selected for a secret leadership role. She has no medical problems and takes no medications. Urine pregnancy test is negative.
Which medication is the best choice for long-term treatment?
Correct answer: Lithium
Why Lithium Is Correct (and What the Exam Is Actually Testing)
This is bipolar I disorder: a manic episode (≥1 week or any duration if hospitalization needed) with classic manic symptoms (decreased need for sleep, grandiosity, pressured speech, distractibility, goal-directed activity/risky behavior). The psychotic features (ideas of reference, grandiose delusions) can occur in mania and do not automatically mean primary psychotic disorder.
Lithium: High-yield role
Lithium is a first-line mood stabilizer for bipolar disorder and is especially important on exams because it:
- Treats acute mania (often combined with an antipsychotic for faster control)
- Provides maintenance to prevent manic and depressive episodes
- Reduces suicide risk (very testable)
- Has a narrow therapeutic index → lots of toxicity questions
When lithium is a great answer
- Bipolar I with recurrent episodes
- Bipolar disorder with classic euphoric mania
- Patients where suicide prevention is a key concern
Mechanism (keep it simple but test-ready)
Lithium’s exact mechanism is complex; board-relevant framing:
- Alters second messenger systems (e.g., inositol signaling) and neuronal excitability
- Downstream effects include mood stabilization
Lithium: The “Must-Know” Table
| What to Know | High-Yield Details |
|---|---|
| Therapeutic range | Roughly 0.6–1.2 mEq/L (toxicity often ≥ 1.5 mEq/L) |
| Key toxicities | Tremor, GI upset, hypothyroidism, nephrogenic diabetes insipidus, weight gain |
| Dangerous toxicity | Confusion, ataxia, seizures, coma (severe) |
| Kidney | Chronic use can cause tubulointerstitial nephritis / CKD |
| Pregnancy | Ebstein anomaly (tricuspid valve malformation) risk in 1st trimester |
| Monitoring | TSH, creatinine/eGFR, lithium level (timed appropriately), pregnancy status when relevant |
| Drug interactions | Thiazides, ACE inhibitors/ARBs, NSAIDs can increase lithium levels |
The Hidden Test: Why Each Distractor Is Wrong (and When It’s Right)
Here’s how to systematically dismantle the answer choices you’ll see in lithium questions.
Distractor 1: Valproate (Valproic acid)
Why it’s wrong here (in many stems):
- If the question is pushing you toward “best long-term, classic bipolar maintenance,” lithium is the prototypical answer.
- Some question writers also hint at lithium by including suicide-risk language or “classic” euphoric mania.
When valproate is the better answer:
- Acute mania needing rapid stabilization (often used with antipsychotics)
- Mixed features or rapid cycling
- Patients who can’t tolerate lithium or have renal disease
High-yield adverse effects (Step 1/2 favorites):
- Neural tube defects (spina bifida) in pregnancy
- Hepatotoxicity and pancreatitis
- Tremor, weight gain
- Thrombocytopenia
- Mechanism clue: increases GABA; also blocks Na+ channels
Distractor 2: Carbamazepine
Why it’s wrong here:
- It can be used for bipolar, but it’s not the go-to “clean” answer unless the stem gives you a reason to avoid lithium/valproate.
When carbamazepine is right:
- Bipolar disorder with acute mania, especially if refractory/intolerant to other mood stabilizers
- Certain comorbid pain syndromes (e.g., trigeminal neuralgia) may push you this direction in integrated vignettes
High-yield toxicities/interactions:
- Agranulocytosis, aplastic anemia (watch CBC)
- Hepatotoxicity
- Hyponatremia (SIADH)
- Teratogenic: neural tube defects
- Big test point: CYP450 inducer → lowers levels of many drugs (including OCPs)
Distractor 3: Lamotrigine
Why it’s wrong here:
- Lamotrigine is not the best for acute mania. It’s much more about bipolar depression and maintenance.
When lamotrigine is right:
- Bipolar depression prevention / maintenance, especially if depressive episodes dominate
- Patients who struggle most with bipolar depression rather than mania
High-yield toxicity:
- Stevens–Johnson syndrome / TEN risk
- Key test move: titrate slowly to reduce risk
- Also dizziness, diplopia
Distractor 4: SSRI (e.g., sertraline, fluoxetine)
Why it’s wrong here:
- Antidepressant monotherapy can trigger mania in bipolar disorder. If the stem is mania, SSRIs are a trap.
When an SSRI might appear “right-ish”:
- Bipolar depression only if paired with a mood stabilizer in selected patients—but this is nuanced and not usually the “best answer” on Step questions unless explicitly guided.
Board tip:
If you see clear mania (decreased need for sleep + grandiosity + pressured speech), avoid antidepressant monotherapy.
Distractor 5: Antipsychotic (e.g., olanzapine, risperidone, quetiapine)
Why it’s wrong as the single best long-term answer in this stem:
- Antipsychotics are excellent for acute mania with psychosis, and many are used in maintenance—but if the question asks for long-term mood stabilization in classic bipolar I, lithium is the canonical pick.
When antipsychotics are right:
- Acute mania, especially with psychosis or agitation
- Patients needing rapid sedation/behavioral control
- Schizoaffective disorder or primary psychotic disorder (depending on longitudinal pattern)
High-yield adverse effect snapshots:
- Second-generation: metabolic syndrome (weight gain, dyslipidemia, hyperglycemia)
- First-generation: EPS, tardive dyskinesia, hyperprolactinemia (esp. risperidone)
Distractor 6: Benzodiazepine (e.g., lorazepam)
Why it’s wrong here:
- It treats symptoms (insomnia/agitation) but doesn’t stabilize mood long term.
When it’s used:
- Short-term adjunct in acute mania while mood stabilizer/antipsychotic takes effect
High-yield cautions:
- Respiratory depression with other sedatives
- Dependence, withdrawal (including seizures)
Lithium Toxicity: How Q-banks Love to Test It
The triad to recognize
Lithium toxicity often shows:
- GI: nausea, vomiting, diarrhea
- Neuro: tremor → ataxia, confusion, seizures
- Renal: polyuria/polydipsia (nephrogenic DI)
Biggest “levels go up” triggers
Remember this like a mnemonic of decreased clearance:
- NSAIDs (reduce renal perfusion)
- ACE inhibitors/ARBs
- Thiazide diuretics
- Dehydration / volume depletion
Clinical logic: Less effective renal clearance → lithium accumulates → toxicity.
Nephrogenic DI mechanism (high yield)
Lithium interferes with ADH signaling in collecting ducts → impaired water reabsorption → dilute urine + high serum osmolality.
Rapid-Fire Exam Pearls (What to Recall in 10 Seconds)
- Bipolar I + maintenance + suicide reduction → Lithium
- Mania + psychosis/agitation → add antipsychotic (often immediately)
- NSAIDs/ACEi/thiazides + lithium → toxicity
- Lithium → hypothyroidism + nephrogenic DI
- Pregnancy: lithium → Ebstein anomaly; valproate/carbamazepine → neural tube defects
- If the question hints at rapid cycling/mixed features → consider valproate
How to Think Like the Test Writer
When a stem screams “mania,” the real question is often:
Do you know the difference between acute control vs long-term stabilization—and can you avoid classic traps?
- Acute mania: antipsychotic ± mood stabilizer (lithium/valproate)
- Long-term maintenance: lithium is the poster child
- Bipolar depression prevention: lamotrigine often shines
- Never reflexively give antidepressant monotherapy in bipolar disorder